the aid library

LIST OPTIONS

Filter

27814

Sort by:

Direction:

Download (22)

View PDF (16)

Clinical Profile and Management of Patient Patients with Ischemic Heart Disease and/or Peripheral Artery Disease in Clinical Practice: The APALUSA Study

Barrios, V.; Escobar, C.; Suarez C. et al. Journal of Clinical Medicine (2022) CC

This study was aimed to ascertain the clinical profile and management of patients with ischemic heart disease (IHD) and/or peripheral artery disease (PAD). In this observational and cross-sectional study developed in 80 hospitals throughout Spain, consecutive adults with stable IHD and/or PAD were i... more

Download (31)

View PDF (17)

A comparison of cardiovascular imaging practices in Africa, North America, and Europe: two faces of the same coin

Lakshmanan, S.; Mbanze, I. European Society of Cardiology (2023) CC

Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide. There are significant differences in the burden of cardiovascular disease and associated risk factors, across high-income countries and low- and middle-income countries. Cardiac imaging by echocardiography, cardia... more

Download (165)

View PDF (255)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (32)

View PDF (18)

What Is Atherosclerosis?

National Heart, Lung, and Blood Institute (2022) CC

Webpage about Atherosclerosis, addressing symptoms, diagnosis, causes and risk factors, prevention, treatment, living with the disease.

Download (9)

View PDF (8)

Burden of Peripheral Artery Disease and Its Attributable Risk Factors in 204 Countries and Territories From 1990 to 2019

Lin, J.; Chen, Y.; Jiang, N. et al. Frontiers in Cardiovascular Medicine (2022) CC

Background: Data on burden of peripheral artery disease (PAD) and its attributable risk factors are valuable for policymaking. We aimed to estimate the burden and risk factors for PAD from 1990 to 2019. Methods: We extracted the data on prevalence, incidence, death, years lived with disability (YLD... more

Download (26)

View PDF (14)

Antimicrobial Resistance Curriculum Assessment Tool for Medical Education

World Health Organisation (WHO) (2024) C_WHO

The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ... more

Download (26)

View PDF (19)

Considerations for border health and points of entry for mpox: interim guidance

World Health Organisation (WHO) (2024) C_WHO

On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Africa constitutes a new public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005)

Download (506)

View PDF (757)

Beim Arzt in Deutschland. Visiting the Doctor in Germany. Chez le Médecin en Allemagne

ICUnet.AG (2016) CC

Schwerpunkt Arabischer und Persischer Raum/Focus on Arab and Persian Culture/ Accent sur le monde arabe et persiqü. Sich besser verstehen, auch ohne die gleiche Sprache zu sprechen. Das gegenseitige Verständnis zwischen Arzt und patient und damit der Weg zur Diagnose soll vereinfacht werden.

Download (347)

View PDF (311)

Beim Arzt in Deutschland

ICU.netAG (2016) C1

Sich besser verstehen, auch ohne die gleiche Sprache zu sprechen: Das ist das Ziel des Patienten-Arzt-Booklets 'Beim Arzt in Deutschland'. Das gegenseitige Verständnis zwischen Arzt und Patient, und damit der Weg zur Diagnose, soll vereinfacht werden. Wichtig dabei: Der kulturelle Hintergrund. Wie ... more

Download (14)

View PDF (16)

Summary of WHO infection prevention and control guideline for Ebola and Marburg disease: a call for evidence based practice

World Health Organisation (WHO) (2024) C_WHO

This article summarises the process involved in developing the updated guideline and includes an infographic to highlight key IPC recommendations from the guideline, following the patient care pathway from the community to a healthcare facility to discharge.

External Link (35)

Google Scholar (31)

WorldCat (84)

Introduction to Marburg Virus Disease

World Health Organisation (WHO) (2024) C_WHO

This course introduces Marburg Virus Disease and outlines the signs, symptoms, diagnosis, transmission routes and epidemiology of the disease. It also discusses prevention and control strategies.

External Link (54)

Google Scholar (84)

WorldCat (108)

Infection prevention and control measures in health-care settings for Ebola or Marburg disease outbreaks

World Health Organisation (WHO) (2024) C_WHO

All health and care workers require the knowledge and skills to prevent the transmission of Ebola virus or Marburg virus when providing care for patients. This course provides an overview of the mode of transmission of these viruses, the personal protective equipment required by health and care work... more

External Link (83)

Google Scholar (66)

WorldCat (112)

Infection Prevention and Control Measures for Marburg Virus Disease

NETEC (2023) CC2

Resource Platform

Download (16)

View PDF (11)

The viral cycle of Ebola virus disease and Marburg virus disease

World Organisation for Animal Health (2019) CC2

Poster

External Link (122)

Google Scholar (82)

WorldCat (77)

Marburg and Ebola Virus Infections

MSD Manual (2023) CC2

Marburg and Ebola are filoviruses that cause hemorrhage, multiple organ failure, and high mortality rates. Diagnosis is with enzyme-linked immunosorbent assay, polymerase chain reaction (PCR), or electron microscopy. Treatment is supportive. Strict isolation and quarantine measures are necessary to ... more

External Link (152)

Google Scholar (137)

WorldCat (97)

Marburg Virus Disease Outbreak in Rwanda

Africa CDC (2024) C_CDC

Situation Report

External Link (53)

Google Scholar (114)

WorldCat (75)

Lessons Learnt from the Marburg Virus Disease (MVD) Outbreak in Tanzania

Africa CDC (2023) C_CDC

On March 16, 2023, the Tanzania Ministry of Health declared an outbreak of an unidentified illness in Bukoba district, Kagera region. A group of seven individuals presented with fever, vomiting, bleeding from various body orifices, and kidney failure, sparking suspicion of a contagious disease. Labo... more

Download (19)

View PDF (11)

'In Control' South Africa - A play about health, stigma and attitudes.

Acacia Study Group YouTube (2022) CC

This video is of a community performance from a theatre play, called 'In Control' South Africa. Our international group of respiratory health researchers found that young people with asthma can feel stigmatised or misunderstood. We therefore developed ths play together with a UK young people's theat... more

Download (18)

View PDF (16)

Asbestosis - Medscape

Jackson, C. D.; Mosenifar, Z.; Medscape (2020) CC2

Asbestosis is a process of diffuse interstitial fibrosis of the lung due to exposure to asbestos dust. Asbestos is the name given to a group of naturally occurring minerals that are resistant to heat and corrosion; these include mineral fibers such as chrysotile, amosite, and crocidolite, among oth... more

External Link (239)

Google Scholar (112)

WorldCat (100)

Disease Outbreak News Marburg virus disease - Rwanda

World Health Organisation (WHO) (2024) C_WHO

On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedi... more